BIOTRONIK Announces US Market Release of Selectra: Advanced New CRT Lead Delivery System

LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, today announced the US market release of the Selectra left ventricular lead delivery system. Selectra delivers a significant advancement in lead placement systems for cardiac resynchronization therapy (CRT) devices.
MORE ON THIS TOPIC